(Q40350652)

19 September 2017

title

A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1. (English)

1 reference

19 September 2017

10

Agnieszka Sirko

1 reference

19 September 2017

8

Anna Góra-Sochacka

1 reference

19 September 2017

1

Anna Stachyra

1 reference

19 September 2017

9

Edyta Kopera

1 reference

19 September 2017

6

Krzysztof Śmietanka

1 reference

19 September 2017

7

Zenon Minta

1 reference

19 September 2017

5

Monika Olszewska

1 reference

19 September 2017

3

Agnieszka Macioła

1 reference

19 September 2017

Maria Pietrzak

2

1 reference

19 September 2017

Anna Protasiuk

series ordinal

4

1 reference

19 September 2017

publication date

31 January 2017

1 reference

19 September 2017

1 reference

19 September 2017

volume

232

1 reference

19 September 2017

page(s)

41-47

1 reference

Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

DNA prime-protein boost vaccination enhances protective immunity against infectious bursal disease virus in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Enhancement of humoral and cellular immunity in chickens against reticuloendotheliosis virus by DNA prime-protein boost vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

DNA vaccines: an historical perspective and view to the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Heterologous prime-boost vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

7 January 2021

Two is better than one.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

DNA vaccination of poultry: The current status in 2015.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Evaluation and attempted optimization of avian embryos and cell culture methods for efficient isolation and propagation of low pathogenicity avian influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

An avian influenza H5N1 virus vaccine candidate based on the extracellular domain produced in yeast system as subviral particles protects chickens from lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Vaccination of gallinaceous poultry for H5N1 highly pathogenic avian influenza: current questions and new technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Highly immunogenic prime–boost DNA vaccination protects chickens against challenge with homologous and heterologous H5N1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

Jump-starting the immune system: prime-boosting comes of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.01.025

10.1016/J.VIRUSRES.2017.01.025

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference